Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of DPPG2-TSL-DOX Combined with Hyperthermia in Soft Tissue Sarcoma
Phase 1
Active, not recruiting
- Conditions
- Sarcoma, Soft Tissue
- Interventions
- Drug: DPPG2-TSL-DOX
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Thermosome GmbH
- Target Recruit Count
- 9
- Registration Number
- NCT05858710
- Locations
- 🇩🇪
Helios Klinikum Berlin-Buch GmbH, Berlin, Germany
🇩🇪Klinikum der Universität München (KUM) Campus Großhadern, Munich, Germany
News
Promising Pipeline for Soft Tissue Sarcoma Treatment Expands with 130+ Therapies in Development
Global soft tissue sarcoma pipeline constitutes 125+ companies developing 130+ treatment therapies, with significant progress in clinical trials across various stages of development.